Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise
beta
Latest Financials
Filings:
By Category
By Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
Company Exhibits:
Indentures
Material Contracts & Credit Agreements
Plans of Reorganization
Articles and Bylaws
Underwriting Agreements
SEC Edgar
NYMOX PHARMACEUTICAL CORP
SIC 2835 · In Vitro & In Vivo Diagnostic Substances
Notes
Support
about
terms
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
beta
Latest Financials
Filings:
Category
Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
SEC Edgar
NYMOX PHARMACEUTICAL CORP
SIC 2835 · In Vitro & In Vivo Diagnostic Substances
Notes
Support
about
terms
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
beta
Latest Financials
Filings:
Category
Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
SEC Edgar
NYMOX PHARMACEUTICAL CORP
SIC 2835 · In Vitro & In Vivo Diagnostic Substances
Notes
Support
about
terms
$
NYMXF
NYMOX PHARMACEUTICAL CORP
CIK:
0001018735
|
SEC Filings
ARTICLES AND BYLAWS
EX-3.1
EX-3.1.txt
2000-02-29T00:00:00Z
EX-3.0
EX-3.0.txt
2000-02-29T00:00:00Z